Ignite Creation Date:
2024-05-06 @ 7:04 AM
Last Modification Date:
2024-10-26 @ 11:44 AM
Study NCT ID:
NCT02465528
Status:
TERMINATED
Last Update Posted:
2019-12-27
First Post:
2015-05-29
Brief Title:
Ceritinib Rare Indications Study in ALK Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-20
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-29
First Submit QC Date:
June 4 2015
Study First Post Date:
2015-06-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-10-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-17
Last Update Post Date:
2019-12-27
Last Update Post Date Type:
ACTUAL